Horace DeLisser, MD, associate dean for diversity and inclusion in undergraduate medical education at the Perelman School of Medicine at the University of Pennsylvania and associate professor of medicine in the pulmonary, allergy, and critical care division, looks forward to the American Thoracic Society (ATS) international conference to reconnect with friends and colleagues and stay up to date on clinical knowledge and controversial topics.
The American Thoracic Society (ATS) international conference offers the opportunity to reconnect, stay up-to-date on clinical knowledge, and learn about controversial topic, says Horace DeLisser, MD, associate dean for diversity and inclusion in undergraduate medical education at the Perelman School of Medicine at the University of Pennsylvania and associate professor of medicine in the pulmonary, allergy, and critical care division.
Transcript
What are you most looking forward to at the ATS 2023 international conference?
I'm looking forward to the opportunity to reconnect with friends and colleagues from the course of my career. I also look forward to this meeting as an opportunity to refresh some of my clinical knowledge and information. I also appreciate the fact that there's a lot of state-of-the-art information, particularly around controversial topics, that, for me, are very instructive and informative.
What else can attendees look forward to at the ATS 2023 international conference?
People come to the meeting for a variety of reasons and expectations. I think for some, as I've mentioned before, the opportunity to learn; it is also the opportunity to reconnect. But I think for others, there is the opportunity to present research and to share data. And, I think there’s just also the fellowship and coming together.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen